Merck KGaA (ETR:MRK - Get Free Report)'s share price dropped 1.4% during mid-day trading on Thursday . The stock traded as low as €142.25 ($145.15) and last traded at €143.00 ($145.92). Approximately 227,393 shares changed hands during trading, The stock had previously closed at €145.00 ($147.96).
Merck KGaA Stock Down 0.7 %
The company has a current ratio of 1.31, a quick ratio of 0.72 and a debt-to-equity ratio of 37.56. The stock has a market cap of $18.35 billion, a P/E ratio of 23.51, a price-to-earnings-growth ratio of 2.37 and a beta of 0.71. The stock's fifty day moving average price is €142.94 and its 200 day moving average price is €154.76.
Merck KGaA Company Profile
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Read More
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
